Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for O88422

Entry ID Method Resolution Chain Position Source
AF-O88422-F1 Predicted AlphaFoldDB

3 variants for O88422

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3319879192 820 V>A No EVA
rs3319870865 892 S>N No EVA
rs3319816615 929 D>N No EVA

No associated diseases with O88422

3 regional properties for O88422

Type Name Position InterPro Accession
domain Ricin B, lectin domain 799 - 925 IPR000772
domain Glycosyltransferase 2-like 489 - 671 IPR001173
domain N-acetylgalactosaminyltransferase 489 - 790 IPR045885

Functions

Description
EC Number 2.4.1.41 Hexosyltransferases
Subcellular Localization
  • Golgi apparatus membrane ; Single-pass type II membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
Golgi apparatus A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways.
Golgi membrane The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.

3 GO annotations of molecular function

Name Definition
carbohydrate binding Binding to a carbohydrate, which includes monosaccharides, oligosaccharides and polysaccharides as well as substances derived from monosaccharides by reduction of the carbonyl group (alditols), by oxidation of one or more hydroxy groups to afford the corresponding aldehydes, ketones, or carboxylic acids, or by replacement of one or more hydroxy group(s) by a hydrogen atom. Cyclitols are generally not regarded as carbohydrates.
metal ion binding Binding to a metal ion.
polypeptide N-acetylgalactosaminyltransferase activity Catalysis of the reaction: UDP-N-acetyl-D-galactosamine + polypeptide = UDP + N-acetyl-D-galactosaminyl-polypeptide. This reaction is the modification of serine or threonine residues in polypeptide chains by the transfer of a N-acetylgalactose from UDP-N-acetylgalactose to the hydroxyl group of the amino acid; it is the first step in O-glycan biosynthesis.

1 GO annotations of biological process

Name Definition
protein O-linked glycosylation A protein glycosylation process in which a carbohydrate or carbohydrate derivative unit is added to a protein via the hydroxyl group of peptidyl-serine, peptidyl-threonine, peptidyl-hydroxylysine, or peptidyl-hydroxyproline, or via the phenol group of peptidyl-tyrosine, forming an O-glycan.

24 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q07537 GALNT1 Polypeptide N-acetylgalactosaminyltransferase 1 Bos taurus (Bovine) PR
Q6WV16 Pgant6 N-acetylgalactosaminyltransferase 6 Drosophila melanogaster (Fruit fly) PR
Q6WV17 Pgant5 Polypeptide N-acetylgalactosaminyltransferase 5 Drosophila melanogaster (Fruit fly) PR
Q9Y117 Pgant3 Polypeptide N-acetylgalactosaminyltransferase 3 Drosophila melanogaster (Fruit fly) PR
Q9NY28 GALNT8 Probable polypeptide N-acetylgalactosaminyltransferase 8 Homo sapiens (Human) PR
Q10472 GALNT1 Polypeptide N-acetylgalactosaminyltransferase 1 Homo sapiens (Human) PR
Q86SR1 GALNT10 Polypeptide N-acetylgalactosaminyltransferase 10 Homo sapiens (Human) PR
Q8IXK2 GALNT12 Polypeptide N-acetylgalactosaminyltransferase 12 Homo sapiens (Human) PR
Q14435 GALNT3 Polypeptide N-acetylgalactosaminyltransferase 3 Homo sapiens (Human) PR
Q8IUC8 GALNT13 Polypeptide N-acetylgalactosaminyltransferase 13 Homo sapiens (Human) PR
Q49A17 GALNTL6 Polypeptide N-acetylgalactosaminyltransferase-like 6 Homo sapiens (Human) PR
Q7Z7M9 GALNT5 Polypeptide N-acetylgalactosaminyltransferase 5 Homo sapiens (Human) PR
O08912 Galnt1 Polypeptide N-acetylgalactosaminyltransferase 1 Mus musculus (Mouse) PR
P70419 Galnt3 Polypeptide N-acetylgalactosaminyltransferase 3 Mus musculus (Mouse) PR
Q921L8 Galnt11 Polypeptide N-acetylgalactosaminyltransferase 11 Mus musculus (Mouse) PR
Q8BGT9 Galnt12 Polypeptide N-acetylgalactosaminyltransferase 12 Mus musculus (Mouse) PR
Q8CF93 Galnt13 Polypeptide N-acetylgalactosaminyltransferase 13 Mus musculus (Mouse) PR
Q29121 GALNT1 Polypeptide N-acetylgalactosaminyltransferase 1 Sus scrofa (Pig) PR
Q10473 Galnt1 Polypeptide N-acetylgalactosaminyltransferase 1 Rattus norvegicus (Rat) PR
Q6UE39 Galnt13 Polypeptide N-acetylgalactosaminyltransferase 13 Rattus norvegicus (Rat) PR
Q925R7 Galnt10 Polypeptide N-acetylgalactosaminyltransferase 10 Rattus norvegicus (Rat) PR
Q9R0C5 Galnt7 N-acetylgalactosaminyltransferase 7 Rattus norvegicus (Rat) PR
Q7K755 gly-11 Putative polypeptide N-acetylgalactosaminyltransferase 11 Caenorhabditis elegans PR
P34678 gly-3 Polypeptide N-acetylgalactosaminyltransferase 3 Caenorhabditis elegans PR
10 20 30 40 50 60
MNKIRKFFRG SGRVLAFIFV ASVIWLLFDM AALRLSFSEI NTGILKEDIM RREQTGFRVE
70 80 90 100 110 120
ADQMTILSPS SRGMRPPRNG AGGKESFRKA ENRVLKVEEN VDQVQRKGKM QFLLGRGKAV
130 140 150 160 170 180
SLWHRTHVQT LPVTLPMQKT QGRDSKPEVS SLHMMSKQTT VLGSEKDSFT VSRGVPLNKT
190 200 210 220 230 240
AEHTETLDKK QEAPENYNLS SDTSKQASQR ALNVTISVRT DRSKQQSQTV TKSSIQFASL
250 260 270 280 290 300
PILKPEEVTV TKKTEAQGKD LKYEAHKARP LLKFTADVGH LKKQSTNETG LGVLPEADGA
310 320 330 340 350 360
KVAPGKKLNF SESQIVIITK EEGQKTDTKE VPNSKIQTVF PKLLGESQGK HIPRSQSQTL
370 380 390 400 410 420
SSPLAPKRAV SQSKPTLAEE LHTARSNLTA KATTVGHQQS HANISENPGK HHVLRIDVTL
430 440 450 460 470 480
SPRDLNAPGQ FGRPVVVPPG KKKEAEQRWK EGNFNVYLSD LIPVDRAIED TRPAGCAEQL
490 500 510 520 530 540
VHNDLPTTSI IMCFVDEVWS ALLRSVHSVL NRSPPHLIKE ILLVDDFSTK DYLKANLDKY
550 560 570 580 590 600
MSQFPKVRIL RLKERHGLIR ARLAGAQNAT GDVLTFLDSH VECNVGWLEP LLERVYLNRK
610 620 630 640 650 660
KVACPVIEVI NDKDMSYMTV DNFQRGVFTW PMNFGWRTIP PDVIAKNGIK ETDIIRCPVM
670 680 690 700 710 720
AGGLFSIDKS YFYELGTYDP GLDVWGGENM ELSFKVWMCG GEIEIIPCSR VGHIFRNDNP
730 740 750 760 770 780
YSFPKDRMKT VERNLVRVAE VWLDEYKELF YGHGDHLIDQ GLDVGNLTQQ RELRKKLKCQ
790 800 810 820 830 840
SFKWYLDNVF PDLKAPVVRA SGVFINLALG KCVSIKNITV VLEDCDGSSE LQQFNYTWVR
850 860 870 880 890 900
LIKHGEWCVA PIPDKGSLTL YPCDNRNNRL KWLHRSASAF HPELVDHIVF ESYQQLLCME
910 920
GNFSQKTLKL AACNPTEPQQ KWKFEKYYDV